NO reverse split desired and only when/if needed for uplisting, said ceo Peterson very firmly in the very recent conference call.
At some point that should be/needs to be given much more credence than it has been to date.
To further make that statement more acceptable, realistic and
credible, all investors need to be aware of is that nasdaq has just made it very clear they have NO interest and will NOT uplist any compnay involved in federally illegal products nor viable banking access.
The irony of all this is to think that private investors will at some point risk multi millions to purchase TRTC is silly given it's illegal status and banking roadblocks.
So, TRTC will continue to grow as an otc pink, soon begin reporting millions in revenue and earnings and it's share price will continue to do the only thing that makes sense, and that is for the share price to dramatically increase given it's revenues and earnings and the hoped for, someday change in legal status. Ironically, this helps investors just the way it is and will be for quite awhile.
Remember, if DEA re-classifies cannabis, which I think is NOT going to happen anytime soon, that only effects medical marijuana and in the bigger scheme of things, not like it also includes recreational marijuana which it doesn't and won't.
The next step when/if it happens, is for more badly needed broad based clinical medical research first.
Bottom line.
Sure seems okay to buy TRTC given the above.
TRTC will very soon be achieve the very things wall street and investors love and that's revenues and profits.